References
- Andersen, A.N., Yue, Z., Meng, F.J., & Petersen, K. (1994). Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Human Reproduction, 9, 1935–1938. doi: https://doi.org/10.1093/oxfordjournals.humrep.a138362.
- Arora, P., Arora, R.S., & Cahill, D. (2014). Essure® for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 121, 527–536. doi: https://doi.org/10.1111/1471-0528.12533.
- Blazar, A.S., Hogan, J.W., Seifer, D.B., Frishman, G.N., Wheeler, C.A., & Haning, R.V. (1997). The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization. Fertility and Sterility, 67, 517–520. doi: https://doi.org/10.1016/S0015-0282(97)80079-9.
- Cai, H.L., Pan, L.Y., Wang, S.F., Tian, Y., Zheng, X.Z., Yang, Y., & Li, K. (2019). Discussion on operative skills in the embolization of hydrosalpinx by hysteroscopic placement of a microcoil. Medicine, 98, e14721. doi: https://doi.org/10.1097/MD.0000000000014721.
- Camus, E., Poncelet, C., Goffinet, F., Wainer, B., Merlet, F., Nisand, I., & Philippe, H.J. (1999). Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: A meta-analysis of published comparative studies. Human Reproduction, 14, 1243–1249. doi: https://doi.org/10.1093/humrep/14.5.1243.
- Casassus, B. (2017). Contraception implant removed from global market. The Lancet, 390, 1576. doi: https://doi.org/10.1016/S0140-6736(17)32548-5.
- Cooper, J.M., Carignan, C.S., Cher, D., Kerin, J.F, & Selective Tubal Occlusion Procedure 2000 Investigators Group. (2003). Microinsert nonincisional hysteroscopic sterilization. Obstetrics & Gynecology, 102, 59–67. doi: https://doi.org/10.1016/S0029-7844(03)00373-9.
- Dar, P., Sachs, G.S., Strassburger, D., Bukovsky, I., & Arieli, S. (2000). Ovarian function before and after salpingectomy in artificial reproductive technology patients. Human Reproduction, 15, 142–144. doi: https://doi.org/10.1093/humrep/15.1.142.
- Dreyer, K., Lier, M.C.I., Emanuel, M.H., Twisk, J.W.R., Mol, B.W.J., Schats, R., … Mijatovic, V. (2016). Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: An RCT. Human Reproduction, 31, 2005–2016. doi: https://doi.org/10.1093/humrep/dew050.
- Galen, D.I., Khan, N., & Richter, K.S. (2011). Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. Journal of Minimally Invasive Gynecology, 18, 338–342. doi: https://doi.org/10.1016/j.jmig.2011.01.016.
- Gelbaya, T.A., Nardo, L.G., Fitzgerald, C.T., Horne, G., Brison, D.R., & Lieberman, B.A. (2006). Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertility and Sterility, 85, 1464–1468. doi: https://doi.org/10.1016/j.fertnstert.2005.10.036.
- Hitkari, J.A., Singh, S.S., Shapiro, H.M., & Leyland, N. (2007). Essure treatment of hydrosalpinges. Fertility and Sterility, 88, 1663–1666. doi: https://doi.org/10.1016/j.fertnstert.2007.01.050.
- Hurskainen, R., Hovi, S.-L., Gissler, M., Grahn, R., Kukkonen-Harjula, K., Nord-Saari, M., & Mäkelä, M. (2010). Hysteroscopic tubal sterilization: A systematic review of the Essure system. Fertility and Sterility, 94, 16–19. doi: https://doi.org/10.1016/j.fertnstert.2009.02.080.
- Johnson, N., van Voorst, S., Sowter, M.C., Strandell, A., & Mol, B.W. (2010). Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database of Systematic Reviews, 2010, CD002125. doi: https://doi.org/10.1002/14651858.CD002125.pub3.
- Katz, E., Akman, M.A., Damewood, M.D., & Garcia, J.E. (1996). Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization. Fertility and Sterility, 66, 122–125. doi: https://doi.org/10.1016/S0015-0282(16)58398-8.
- Kerin, J.F., Cooper, J.M., Price, T., Herendael, B.J., Cayuela-Font, E., Cher, D., & Carignan, C.S. (2003). Hysteroscopic sterilization using a micro-insert device: Results of a multicentre Phase II study. Human Reproduction, 18, 1223–1230. doi: https://doi.org/10.1093/humrep/deg256.
- Kontoravdis, A., Makrakis, E., Pantos, K., Botsis, D., Deligeoroglou, E., & Creatsas, G. (2006). Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertility and Sterility, 86, 1642–1649. doi: https://doi.org/10.1016/j.fertnstert.2006.05.032.
- Lass, A., Ellenbogen, A., Croucher, C., Trew, G., Margara, R., Becattini, C., & Winston, R.M. (1998). Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertility and Sterility, 70, 1035–1038. doi: https://doi.org/10.1016/S0015-0282(98)00357-4.
- Li, Q., Kuang, Y.P., Yang, H.L., Fu, Y.L., Sun, H., Fan, L.P., & Shi, H.B. (2008). [Application of fallopian tube embolization before in vitro fertilization and embryo transfer dealing with the hydrosalpinx]. Zhonghua Fu Chan Ke Za Zhi, 43, 414–417. doi: https://doi.org/10.3321/j.issn:0529-567x.2008.06.004.
- Matorras, R., Rabanal, A., Prieto, B., Diez, S., Brouard, I., Mendoza, R., & Exposito, A. (2013). Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. European Journal of Obstetrics & Gynecology and Reproductive Biology, 169, 54–59. doi: https://doi.org/10.1016/j.ejogrb.2013.02.008.
- Mijatovic, V., Veersema, S., Emanuel, M.H., Schats, R., & Hompes, P.G. (2010). Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertility and Sterility, 93, 1338–1342. doi: https://doi.org/10.1016/j.fertnstert.2008.11.022.
- Ozgur, K., Bulut, H., Berkkanoglu, M., Coetzee, K., & Kaya, G. (2014). ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients. Reproductive Biomedicine Online, 29, 113–118. doi: https://doi.org/10.1016/j.rbmo.2014.03.005.
- Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. (2008). Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertility and Sterility, 90, S66–S68. doi: https://doi.org/10.1016/j.fertnstert.2008.08.089.
- Rosenfield, R.B., Stones, R.E., Coates, A., Matteri, R.K., & Hesla, J.S. (2005). Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertility and Sterility, 83, 1547.e11–1550. doi: https://doi.org/10.1016/j.fertnstert.2004.10.056.
- Smith, R.D. (2010). Contemporary hysteroscopic methods for female sterilization. International Journal of Gynecology & Obstetrics, 108, 79–84. doi: https://doi.org/10.1016/j.ijgo.2009.07.026.
- Strandell, A., Waldenstrom, U., Nilsson, L., & Hamberger, L. (1994). Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Human Reproduction, 9, 861–863. doi: https://doi.org/10.1093/oxfordjournals.humrep.a138606.
- Thebault, N., Broux, P.L., Moy, L., & Vialard, J. (2012). Utilisation du micro-implant Essure® pour exclusion d’hydrosalpinx dans un contexte d’infertilité [Utilization of Essure® micro-insert for hydrosalpynx occlusion in infertile women]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 41, 145–150. doi: https://doi.org/10.1016/j.jgyn.2011.12.003.
- Veeck, L.L. (1988). Oocyte assessment and biological performance. Annals of the New York Academy of Sciences, 541, 259–274. doi: https://doi.org/10.1111/j.1749-6632.1988.tb22263.x.
- Yang, Y., & Ma, C.H. (2015). Application of proximal tubal occlusion by microcoils as a treatment for hydrosalpinges prior to IVF or ICSI. Journal of Practical Obstetrics and Gynecology, 31, 169–171. Retrieved from: https://caod.oriprobe.com/articles/44299637/shu_luan_guan_shuan_du_shu_de_lin_chuang_ying_yong.htm
- Ye, X.P., Yang, Y.Z., & Sun, X.X. (2015). A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. American Journal of Obstetrics and Gynecology, 212, 53 e1–53.e10. doi: https://doi.org/10.1016/j.ajog.2014.07.027.
- Zeyneloglu, H.B., Arici, A., & Olive, D.L. (1998). Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertility and Sterility, 70, 492–499. doi: https://doi.org/10.1016/S0015-0282(98)00200-3.